Atlas Trials

Incidence and Severity of Residual Neuromuscular Blockade

Clinical trial NCT02660398 · COMPLETED

Trial details

NCT number
NCT02660398
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Residual Neuromuscular Blockade
Start date
2016-01-01
Primary completion
2017-01-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.